Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH

This study has been completed.

Study NCT00359905 Information provided by Recordati Industria Chimica e Farmaceutica S.p.A.

First Received: August 2, 2006 Last Updated: February 18, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	January 2008
Primary Completion Date:	May 2007 (Final data collection date for primary outcome measure)

No publications provided by Recordati Industria Chimica e Farmaceutica S.p.A.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Chapple CR, Montorsi F, Tammela TL, Wirth M, Koldewijn E, Fernández Fernández E; European Silodosin Study Group. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe. Eur Urol. 2011 Mar;59(3):342-52. Epub 2010 Nov 10.